Netflix, earnings per share
Digest more
Q2 Earnings Snapshot
Digest more
Marsh & McLennan Companies (NYSE:MMC) posted Thursday second-quarter earnings that rose past the average analyst estimate as revenue momentum continued across its business units, along with acquisition tailwinds.
Summit Therapeutics surged by 16.05 percent on Wednesday to close at $28.27 apiece, leading the rally of the overall biotechnology sector, as investors repositioned portfolios ahead of the release of
Stocks jumped to record highs on Thursday, with investors brushing off the latest Trump-Powell drama to focus on strong earnings and robust economic data.
PepsiCo offers strong dividend growth potential with a stable credit rating and a 14% discount on fair value. Click here to read my most recent analysis.
Netflix is due to report second-quarter results after the close of trading Thursday, with Wall Street eagerly anticipating a strong kickoff to media earnings season from the giant streamer. "Currently,
PKG is poised for Q2 earnings growth, with solid packaging demand offsetting weaker paper volumes and boosting margins.
Johnson & Johnson shows steady growth in Q2, driven by medtech and oncology, yet talc litigation overshadows. Click for my JNJ earnings update.